F.D.A. Approves New Obesity Drug That Will Compete With Wegovy

NYT HEALTH: F.D.A. Approves New Obesity Drug That Will Compete With Wegovy
By Gina Kolata
Section: Health
Source: New York Times
Published Date: November 8, 2023 at 02:00AM

Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.

Read more: https://www.nytimes.com/2023/11/08/health/fda-tirzepatide-obesity-zepbound-wegovy.html?partner=IFTTT